Page last updated: 2024-10-31

milrinone and Constriction, Pathological

milrinone has been researched along with Constriction, Pathological in 2 studies

Research Excerpts

ExcerptRelevanceReference
"The therapeutic action of adenocine during cardiac insufficiency (heart failure) caused by ischemic (stenosis) or reperfusion (removal of ligature) injury to the myocardium prevents depletion of ATP, the major energy source for myocytes in the right and left ventricles, and a drop in NAD/NADH ratio."3.77Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency. ( Gongadze, NV; Sukoyan, GV, 2011)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yagami, K1
Yamawaki-Ogata, A1
Satake, M1
Kaneko, H1
Oshima, H1
Usui, A1
Ueda, Y1
Narita, Y1
Sukoyan, GV1
Gongadze, NV1

Other Studies

2 other studies available for milrinone and Constriction, Pathological

ArticleYear
Prevention of arterial graft spasm in rats using a vasodilator-eluting biodegradable nano-scaled fibre.
    Interactive cardiovascular and thoracic surgery, 2013, Volume: 17, Issue:1

    Topics: Absorbable Implants; Animals; Arterial Occlusive Diseases; Calcium Channel Blockers; Constriction, P

2013
Mechanism of cardioprotective effect of adenocine and non-glycoside cardiotonic drugs during experimental chronic cardiac insufficiency.
    Bulletin of experimental biology and medicine, 2011, Volume: 150, Issue:5

    Topics: Acetyldigoxins; Adenosine; Adenosine Triphosphate; Animals; Apoptosis; Cardiotonic Agents; Constrict

2011